Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 2 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Gliosarcoma 1 Glioblastoma 1 Brain Neoplasms 1

Interventions

Temozolomide 28 Radiosurgery 19 Radiotherapy 17 Bevacizumab 12 Magnetic Resonance Spectroscopy 9 Radiation 6 Erlotinib Hydrochloride 6 Carboplatin 6 Topotecan 5 Nivolumab 5 Mental Status and Dementia Tests 5 Irinotecan 5 Capecitabine 5 pembrolizumab 4 dabrafenib 4 Trastuzumab 4 Sunitinib 4 Pemetrexed 4 Ipilimumab 4 Filgrastim 4 Cyclophosphamide 4 Aminolevulinic Acid 4 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 4 cabozantinib 3 Vorinostat 3 TPI-287 3 Specimen Handling 3 Radiotherapy, Intensity-Modulated 3 Methylphenidate 3 Lomustine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Brain Neoplasms × Chloroquine × Clear all

NCT01894633 2024-01-24

CLQ

Instituto Nacional de Cancerologia de Mexico

Phase 2 Terminated

Brain Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡